Bone marrow immunoscintigraphy for the detection of skeletal metastases in patients with breast cancer

Nuclear Medicine Communications

Volumn 20, Issue 2, 1999, Pages 135-144

  Lacica, Miodrag ^a   Bokulica, T ^a   Lukack, J ^a   Kovackica, K ^a   Kusica, Z ^a   Baum, R P ^b  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; MEDRONATE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINE METASTASIS;

EID: 0032894666     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199902000-00005     Document Type: Article

References (27)

1. Vogler JB, Murphy WA. Bono marrow imaging. Radiology 1988; 168: 679-693.
2. Kesko SN. Recent advances in bone marrow scanning, Eur J Nucl Med 1991; 18: 203-221.
3. Munz DL, Sandrock D, Rilinger N. Comparison of immu-noscintigrophy and colloid scintigraphy of bone marrow (letter). Lancet 1990; 1: 258.
4. Reške SN, Karstens H, Clockner W et al. Rad ioim mu noimaging lor diagnosis of bone marrow involvement in breast cancer and malignant lymphoma. Lancet 1989; 1: 299-301.
5. Flsing LG, Reiners C1IR. Scintigraphic detection of infection: Are human anti-mouse antibodies a relevant problem in immunoscintigraphy with anti-granulocyte antibodies? Nucl Mal Commun 1995; 16: 63-65.
6. Datz FI, Morton KA. New radiopharmaceuticals for detecting infection. In Katzberg RW, ed. Progress in clinical radiology, Invest Radiol 1993; 28: 356-365.
7. Dunckor CM, Carrio I, Berna L et al. Radioimmune imaging of bone marrow in patients with suspected bone métastasés from primary breast cancer. J Nucl Med 1990; 31: 1450-1455.
8. Lee KH, Chung JK, Choi CW et al. Tcehnetium-99m-labeled antigranulocyte antibody bone marrow scintigraphy. J Nucl Med 1995; 36: 1800-1805.
9. Lacić M, Bokulić T, Kusić Z, Kovačić K, Lukač J, Daković N. Disparity of bone scan and bone marrow scintigraphy with Tc-labeled antigranulocyte BW 250 /183 antibody in patients with breast cancers (abstract). Eur J Nucl Med 1994; 21: 832.
10. Bosslet K, Lübon C., Schwarz A et al. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epilopes detectable on carcinoem-bryonic antigen (CHA). Int J Cancer 1985; 36: 75-84.
11. m-lab-eled monoclonal antibodies (abstract). J Nucl Med 1987; 28: 721.
12. Steinsträsser A, Schorlemmer HU, Schwarz A, Kuhlmann L, Bosslet K. A novel 99Tc-m labelled antibody for in vivo targeting ol granulocytes (abstract). J Nucl Med 1988; 29: 925.
13. Steinsträsser A, Schorlemmer HU, Schwarz A, Kuhlmann I., Bosslet K. Targeting of granulocytes by a novel monoclonal antibody labelled with 99Tc-m. In: Schmidt I IA, Buraggi CL, eds. Nuclear medicine: Trends and possibilities in nuclear medicine. Stuttgart: Schattauer, 1989: 106-109.
14. Schicha H, Franke M, Smorlorz J, Linden A, Waters W, Diehl V. Diagnostic strategies and staging procedures for I lodgkin’s lymphoma: Bone marrow scintigraphy and magnetic resonance imaging. Recall Results Cancer Res 1989; 117: I 12.
15. Linden A, Xankovilch R, Theissen P, Diehl V, Schicha II. Malignant lymphoma: Bone marrow imaging versus biopsy. Radiology1989; 173: 335.
16. Kamby C, Vejborg I, Daugaard S et al. Clinical and radiological characteristics of bone melastases in breast cancer. Cancer 1987; 60: 2524-2531.
17. Fogelman I. Bone scanning. In: Maisey MN, Britton Kli, Cilday DL, eds. Clinical nuclear medicine. London: Chapman & Hall, 1991: 135.
18. Rappaporl AH, Iloffer IB, Cenanl HK. Unifocal bone findings by scintigraphy: Clinical significance in patients with known primary cancer. West J Med 1978; 129: 188-192.
19. DiStefano A, Tashima CK, Yap Y, I lortobagyi GN. Bone marrow metastasis without cortical bone involvement in breast cancer patients. Cancer 1979; 44: 196-198.
20. Kamby C, Culdhammer B, Vejborg I et al. The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer 1987; 60: 1306-1312.
21. Lind P, Langsleger W, Költringer P, Dimai I IP, Passl R, Eber O. Immunoscintigraphy of inflammatory processes with a technetium-99m-labeled monoclonal antigranulocyte antibody (MAb BW 250/183). J Nucl Med 1990; 31: 417-423.
22. Kroiss A, Bock F, Perneczky G et al. Immunszinligraphic zur Aufdeckung von Hntzundungsherden boi Knochen-und Gelenkserkrankungen. Wien Klin Woelicuschr 1990; 102: 713-717.
23. Siddiqui AR, Oseas RS, Wellman I IN, Doerr DR, Baehner RL. Evaluation of bone marrow scanning with technetium-99m-sulfur colloid in pediatric oncology. J Nucl Med 1979; 20: 379-386.
24. Lacić M, Bokulić T, Kova čić K, Lukać J, Kusić Z. Qualitative and semi-quantitative radioimmunoscintigraphic evaluation of bone marrow expansion in the skull: Correlation with bone scan (abstract). Nucl Med Commun 1995; 16: 251.
25. Bonner H. The blood and the lymphoid organs. In: Rubin E, Farber JL, eds. Pathology. Philadelphia, PA: J.B. Lippin-cott, 1988: 1014.
26. Bosslet K, Auerbach B, Höffken H, Joseph K. Frequency and relevance of the human anti-mouse immunoglobulin (HAMA) response in immunoscintigraphy. Nucl Med 1989; 28: 149.
27. Joseph K, Höffken H, Bosslet K, Schorlemmer HU. In vivo labelling of granulocytes with 99mTc anti-NCA monoclonal antibodies for imaging inflammation. Eur J Nucl Med 1988; 14: 367-373.